These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8463521

  • 1. L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results.
    Burke WJ, Ranno AE, Roccaforte WH, Wengel SP, Bayer BL, Willcockson NK.
    J Am Geriatr Soc; 1993 Apr; 41(4):367-70. PubMed ID: 8463521
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition.
    Tariot PN, Cohen RM, Sunderland T, Newhouse PA, Yount D, Mellow AM, Weingartner H, Mueller EA, Murphy DL.
    Arch Gen Psychiatry; 1987 May; 44(5):427-33. PubMed ID: 3107514
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. L-deprenyl therapy improves verbal memory in amnesic Alzheimer patients.
    Finali G, Piccirilli M, Oliani C, Piccinin GL.
    Clin Neuropharmacol; 1991 Dec; 14(6):523-36. PubMed ID: 1773423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.
    Martignoni E, Bono G, Blandini F, Sinforiani E, Merlo P, Nappi G.
    J Neural Transm Park Dis Dement Sect; 1991 Dec; 3(1):15-25. PubMed ID: 1712206
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tranylcypromine compared with L-deprenyl in Alzheimer's disease.
    Tariot PN, Sunderland T, Cohen RM, Newhouse PA, Mueller EA, Murphy DL.
    J Clin Psychopharmacol; 1988 Feb; 8(1):23-7. PubMed ID: 3127432
    [Abstract] [Full Text] [Related]

  • 18. L-deprenyl and physostigmine for the treatment of Alzheimer's disease.
    Marin DB, Bierer LM, Lawlor BA, Ryan TM, Jacobson R, Schmeidler J, Mohs RC, Davis KL.
    Psychiatry Res; 1995 Oct 16; 58(3):181-9. PubMed ID: 8570774
    [Abstract] [Full Text] [Related]

  • 19. Preliminary communication. A double-blind placebo-controlled trial of L-tryptophan to assess the degree of cognitive and behavioural improvement in patients with Alzheimer-type dementia and to compare differential response in clinical sub-groups.
    Bentham PW.
    Int Clin Psychopharmacol; 1990 Oct 16; 5(4):261-72. PubMed ID: 2081897
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.